Type | Public | |
Founded | 1833 | |
HQ | Irving, TX, US | Map |
Website | mckesson.com | |
Employee Ratings | More | |
Overall Culture | C- | More |
USD | |
---|---|
Revenue (Q3, 2021) | 62.6b |
Gross profit (Q3, 2021) | 3.2b |
Gross profit margin (Q3, 2021), % | 5% |
Net income (Q3, 2021) | (6.2b) |
EBIT (Q3, 2021) | (7.4b) |
Market capitalization (26-Feb-2021) | 27.0b |
Closing stock price (26-Feb-2021) | 169.5 |
Cash (31-Dec-2020) | 3.6b |
EV | 32.9b |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Cash | 2.2b | 2.1b | 1.8b | 1.9b | 1.4b | 2.1b | 2.6b | 3.1b | 3.6b |
Accounts Receivable | 19.1b | 19.2b | 18.9b | 19.3b | 19.0b | 18.8b | 17.8b | 19.3b | 18.9b |
Prepaid Expenses | 558.0m | 542.0m | 587.0m | 590.0m | 657.0m | 618.0m | 850.0m | 701.0m | 688.0m |
Inventories | 16.4b | 16.7b | 17.0b | 16.6b | 16.4b | 17.0b | 16.6b | 18.4b | 19.2b |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (80.0m) | 473.0m | 999.0m | 477.0m | (200.0m) | 42.0m | 494.0m | 1.1b | (5.1b) |
Depreciation and Amortization | 235.0m | 475.0m | 714.0m | 229.0m | 463.0m | 691.0m | 217.0m | 439.0m | 666.0m |
Inventories | (114.0m) | (398.0m) | (756.0m) | 145.0m | 331.0m | (689.0m) | 238.0m | (1.4b) | (2.0b) |
Accounts Payable | 32.0m | 1.2b | 175.0m | 127.0m | (1.2b) | (929.0m) | (4.2b) | (1.3b) | (1.2b) |
USD | FY, 2018 |
---|---|
EV/EBIT | 45.3 x |
EV/CFO | 7.9 x |
Revenue/Employee | 3.6m |
Debt/Equity | 0.8 x |
Debt/Assets | 0.1 x |
Financial Leverage | 6 x |
P/E Ratio | 440.2 |
Company Name | Date | Deal Size |
---|---|---|
Echo | June 19, 2019 | |
Medical Specialties Distributors | April 25, 2018 | |
Well.ca | December 04, 2017 | |
RxCrossroads | November 06, 2017 | |
CoverMyMeds | January 25, 2017 | $1.10 b |
HealthQx | July 12, 2016 | |
Vantage Oncology | April 04, 2016 | $525 m |
Rexall | March 02, 2016 | $2.10 b |
Biologics | February 25, 2016 | $1.20 b |
UDG Healthcare | September 16, 2015 | €408 m |
McKesson revenue breakdown by business segment: 79.4% from U.S. Pharmaceutical and Specialty Solutions, 11.9% from European Pharmaceutical Solutions, 5.2% from Other and 3.6% from Other
McKesson revenue breakdown by geographic segment: 16.6% from Foreign and 83.4% from United States
McKesson has 21.87k Twitter Followers. The number of followers has increased 0.2% month over month and increased 0.5% quarter over quarter
6.3k
Tweets
282
Following
21.9k
Followers
12
Tweets last 30 days
5.3
Avg. likes per Tweet
100%
Tweets with engagement
C-
68/100
D+
65/100
C-
65/100
D
68/100
When was McKesson founded?
McKesson was founded in 1833.
Who are McKesson key executives?
McKesson's key executives are Brian S. Tyler, Jennifer Carter and Tracy Faber.
How many employees does McKesson have?
McKesson has 60,000 employees.
What is McKesson revenue?
Latest McKesson annual revenue is $231.1 b.
What is McKesson revenue per employee?
Latest McKesson revenue per employee is $3.9 m.
Who are McKesson competitors?
Competitors of McKesson include R1 RCM, Omnicell and EMIS Group.
Where is McKesson headquarters?
McKesson headquarters is located at 6555 State Hwy 161, Irving.
Where are McKesson offices?
McKesson has offices in Irving, Atlanta, Henrico, Livonia and in 5 other locations.
How many offices does McKesson have?
McKesson has 10 offices.
Receive alerts for 300+ data fields across thousands of companies